Company profile for Oranomed

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

The idea of using 212Pb for medical purposes germinated in the mind of Patrick Bourdet, Orano Med's founder. In the early 2000s, Areva (now Orano) looked at opportunities to use material derived from its core nuclear energy activities. Nuclear medicine and Targeted Alpha Therapy quickly appeared very promising: tangible scientific prospects but problematic supply of isotopes that could be overcome. With sufficient resources to...
The idea of using 212Pb for medical purposes germinated in the mind of Patrick Bourdet, Orano Med's founder. In the early 2000s, Areva (now Orano) looked at opportunities to use material derived from its core nuclear energy activities. Nuclear medicine and Targeted Alpha Therapy quickly appeared very promising: tangible scientific prospects but problematic supply of isotopes that could be overcome. With sufficient resources to produce 212Pb in larger quantities, the project soon emerged to demonstrate the feasibility of extracting and purifying this isotope. Successful results followed by conclusive preclinical studies

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
700 Klein Road, Plano, TX 75074
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2025-12-04/orano-med-enters-next-phase-of-collaboration-with-roche-1

PHARMIWEB
04 Dec 2025

https://www.businesswire.com/news/home/20250912698011/en/Orano-Med-Achieves-Key-Milestone-in-French-ATEF-Facility-Construction-an-Essential-Asset-for-Large-Scale-Production-of-Innovative-Lead-212-based-Therapies

BUSINESSWIRE
12 Sep 2025

https://www.businesswire.com/news/home/20250626176840/en/Orano-Med-Inaugurates-Expansion-of-its-U.S.-Research-and-Development-Center-in-Texas

BUSINESSWIRE
26 Jun 2025

https://www.fiercepharma.com/pharma/after-us-plant-reveal-frances-orano-med-lays-out-eu250m-build-another-radioligand-facility

FIERCE PHARMA
15 Nov 2024

https://www.globenewswire.com/news-release/2024/10/17/2964590/0/en/Press-Release-Sanofi-and-Orano-join-forces-to-develop-next-generation-radioligand-medicines.html

GLOBENEWSWIRE
17 Oct 2024

https://www.clinicaltrialsarena.com/news/patient-enrollment-completed-for-phase-ii-trial-of-alphamedix-in-neuroendocrine-cancer/

CLINICAL TRIALS ARENA
16 May 2023

ABOUT THIS PAGE

Contact Oranomed and get a quotation

Oranomed is a supplier offers 2 products (APIs, Excipients or Intermediates).

Find a price of Alphamedix bulk with DMF offered by Oranomed

Find a price of Lead bulk with DMF offered by Oranomed

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty